| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $20.6M | +449.9% |
| R&D Expense | $22.3M | -15.6% |
| SG&A Expense | $14.4M | -0.4% |
| Operating Income | -$16.1M | +56.7% |
| Pre-tax Income | -$8.6M | +59.3% |
| Income Tax | $0 | -100.0% |
| Net Income | -$8.6M | +59.6% |
| EPS (Basic) | -$0.17 | +61.4% |
| EPS (Diluted) | -$0.17 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.3M | +32.4% |
| Short-term Investments | $18.8M | -56.6% |
| Current Assets | $40.4M | -44.1% |
| Total Assets | $59.0M | -34.9% |
| Current Liabilities | $5.7M | -76.2% |
| Total Liabilities | $9.7M | -72.9% |
| Stockholders' Equity | $49.4M | -10.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.3M | +78.0% |
| Investing Cash Flow | $24.3M | +295.2% |
| Financing Cash Flow | -$14.2M | — |
| +61.4% |